Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

Hiemcke-Jiwa, L.S. (Laura S.), P. Leguit (Piet), Radersma-van Loon, J.H. (Joyce H.), J. Westerweel (Jerry), Rood, J.J.M. (Johannes J. M.), J.K. Doorduijn (Jeanette), Huibers, M.M.H. (Manon M. H.) and M.C. Minnema (Monique)

2017-08-30

Additional Metadata
Persistent URL	doi.org/10.1080/10428194.2017.1369074, hdl.handle.net/1765/101714
Journal	Leukemia and Lymphoma
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Hiemcke-Jiwa, L.S. (Laura S.), Leguit, P., Radersma-van Loon, J.H. (Joyce H.), Westerweel, J., Rood, J.J.M. (Johannes J. M.), Doorduijn, J., … Minnema, M. (2017). Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement. Leukemia and Lymphoma, 1–4. doi:10.1080/10428194.2017.1369074

Publication